Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
Learn More
Invitrogen™ NOC2L Polyclonal Antibody
Rabbit Polyclonal Antibody
Supplier: Invitrogen™ PA575404
Description
The antibody was affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogen and the purity is > 95% (by SDS-PAGE).
INHAT (inhibitor of acetyltransferases) complex binds to histones and masks them from being substrate for acetyltransferase. Endogenous INHAT subunits, which include the Set/TAF-Ibeta oncoprotein, associate with chromatin in vivo and can block coactivator mediated transcription when transfected in cells.
Specifications
NOC2L | |
Polyclonal | |
Unconjugated | |
NOC2L | |
AA410003; AF155546; DKFZp564C186; FLJ35172; hypothetical protein LOC508638; NET15; NET7; NIR; NOC2 like nucleolar associated transcriptional repressor; NOC2L; NOC2L nucleolar associated transcriptional repressor; NOC2-like; NOC2-like nucleolar associated transcriptional repressor; NOC2-like protein; novel INHAT (inhibitor of histone acetyltransferase) repressor; novel INHAT repressor; nucleolar complex associated 2 homolog; nucleolar complex associated 2 homolog (S. cerevisiae); nucleolar complex protein 2 homolog; PPP1R112; Protein NOC2 homolog; protein phosphatase 1, regulatory subunit 12; RGD1309387 | |
Rabbit | |
Antigen affinity chromatography | |
RUO | |
26155, 313777, 57741 | |
Store at 4°C short term. For long term storage, store at -20°C, avoiding freeze/thaw cycles. | |
Liquid |
Immunohistochemistry (Paraffin) | |
1 mg/mL | |
PBS with 50% glycerol and 0.02% sodium azide; pH 7.2 | |
Q9WV70, Q9Y3T9 | |
NOC2L | |
Synthetic peptide corresponding to amino acids 602-650 of Human NOC2L. | |
100 μL | |
Primary | |
Human, Mouse, Rat | |
Antibody | |
IgG |
Product Content Correction
Your input is important to us. Please complete this form to provide feedback related to the content on this product.
Product Title
Spot an opportunity for improvement?Share a Content Correction